Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00201916
Status:
COMPLETED
Last Update Posted:
2010-08-17
First Post:
2005-09-13
Brief Title:
Shorter Radiation Schedule for the Treatment of Prostate Cancer
Sponsor:
Ontario Clinical Oncology Group OCOG
Organization:
Ontario Clinical Oncology Group OCOG
Study Overview
Official Title:
A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To improve the management of patients with early stage prostate cancer
Detailed Description:
To compare the efficacy of a shorter radiation fractionation schedule to the prostate 5250 cGy20 fractions over 28 days with a conventional schedule 6600 cGy33 fractions over 45 days in men receiving radiotherapy for Stage T1a moderately or poorly differentiated or T1b T1c or T2 prostate cancer The primary outcome is local control in the prostate and secondary outcomes include toxicity disease free survival survival quality of life and economics
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CAN-OCOG-V95-0687 | None | None | None |